Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Isofol Medical AB (publ) | 700,000 | net | 03 Aug 2020 | tx 4+700,000 |
| Oncopeptides AB | 56,942 | net | 28 Jun 2024 | tx 3+56,942 |
| Biovica International AB | 50,000 | net | 14 Dec 2021 | tx 2+50,000 |
| Oncopeptides AB | 15,700 | net | 22 Feb 2017 | tx 2+15,700 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Jun 2024 | GRANT_AWARD | Oncopeptides AB | 43,292 | 0.00 SEK | |
| 14 Dec 2021 | PURCHASE | Biovica International AB | 25,000 | 3.94 SEK | derivfirst after silence |
| 28 Oct 2020 | PURCHASE | Biovica International AB | 25,000 | 3.31 SEK | derivfirst after silence |
| 03 Aug 2020 | GRANT_AWARD | Isofol Medical AB (publ) | 250,000 | 37.00 SEK | deriv |
| 03 Jun 2020 | GRANT_AWARD | Oncopeptides AB | 5,800 | 0.00 SEK | |
| 28 Feb 2017 | PURCHASE | Oncopeptides AB | 7,850 | 46.00 SEK | |
| 22 Feb 2017 | PURCHASE | Oncopeptides AB | 7,850 | 46.00 SEK | |
| 19 Jan 2018 | PURCHASE | Isofol Medical AB (publ) | 100,000 | 17.00 SEK | |
| 19 Jan 2018 | PURCHASE | Isofol Medical AB (publ) | 100,000 | 17.00 SEK | |
| 22 Feb 2017 | PURCHASE | Oncopeptides AB | 7,850 | 46.00 SEK |
2 purchases reported after at least 12 months of silence — most recent on 14 Dec 2021.